Business Context and Reporting Period
This Form 8-K Current Report was filed by AEHR TEST SYSTEMS on August 31, 2024. The filing addresses Item 5.02 regarding the departure of directors or certain officers and compensatory arrangements. Specifically, the Company entered into new Change in Control and Severance Agreements with its President and CEO, Gayn Erickson; Executive Vice President of Finance and CFO, Chris P. Siu; and other executive officers.
Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation terms and severance benefits.
Material Changes
The primary material change is the execution of new Severance Agreements on August 31, 2024, which supersede and replace all prior change in control and severance agreements for the named executives. These agreements define enhanced benefits triggered by a "qualifying termination of employment" (involuntary termination without cause or resignation for good reason) during a "change in control period."
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or general management commentary regarding business operations. It details the specific terms of the new severance packages:
- Change in Control Period Benefits:
- CEO (Mr. Erickson): 24 months base salary, 200% target annual cash incentive, prorated incentive, full equity acceleration, and 24 months healthcare.
- CFO (Mr. Siu): 18 months base salary, 150% target annual cash incentive, prorated incentive, full equity acceleration, and 18 months healthcare.
- Other Executives: 12 months base salary, 100% target annual cash incentive, prorated incentive, full equity acceleration, and 12 months healthcare.
- Outside Change in Control Period Benefits:
- CEO: 12 months base salary, prorated incentive, 12 months equity acceleration, and 12 months healthcare.
- CFO: 9 months base salary, prorated incentive, 9 months equity acceleration, and 9 months healthcare.
- Other Executives: 6 months base salary, prorated incentive, 6 months equity acceleration, and 6 months healthcare.
- Death or Disability: Benefits generally align with the "outside change in control" terms, with specific provisions for supplemental benefits plans in the case of disability.
All payments are contingent upon the executive providing a general release of claims.
Key Facts for Investor Verification
- Verify the specific definitions of "cause" and "good reason" in the full text of the Severance Agreements (Exhibit 10.1) to understand the triggers for these payouts.
- Confirm the duration of the "change in control period" for each executive (24 months for CEO, 18 months for CFO, 12 months for others) following a potential acquisition.
- Review the impact of these enhanced severance obligations on the Company's future cash flow and potential liability in the event of a merger or acquisition.
- Note that this filing does not provide updated financial results; investors should refer to the most recent 10-Q or 10-K for financial performance.